EA treatment can reduce RGC damage and slow myopia progression in guinea pigs with FDM, which may be related to the activation of the mitophagy-associated PINK1/Parkin signaling pathway through lncRNA-XR_002789763.1 sponging of miR-342-5p in these cells. The gene discussed is PINK1; the disease is myopia.